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ABSTRACT

Myelination and node of Ranvier formation play an important role in saltatory
conduction of axonal action potentials in the peripheral nervous system (PNS). Degeneration or
damage of this myelin can lead to impairment in the conduction of signals by the axons, and
cause deficits in sensory and motor function. Currently, animal-based models are the primary
method used to study myelination; however, data generated in animal models generally
translate poorly to humans, especially as applied to drug discovery. In order to accurately study
myelination in humans without having to rely on human testing, an engineered in vitro model
of myelination could go a long way in helping us understand the mechanisms of myelination, as
well as provide a platform to test drugs or therapeutics to treat diseases that affect
myelination. Here we report the complete development and characterization of the first
human myelination model using human primary Schwann cells (SCs) and human iPSC-derived
motoneurons (iPSC-MNs) as well as some data collected from furthering this work utilizing iPSC
derived Schwann cells. Myelination and node of Ranvier formation in co-cultured iPSC human
motoneurons and primary human SCs were characterized via flow cytometry,
immunocytochemistry, and 3D confocal Raman microscopy, and furthering of this work using
iPSC derived human Schwann cells characterized using immunocytochemistry is also presented.
This novel human-based myelination model will be a more accurate tool when it comes to the
study of myelination and demyelinating diseases in humans, as well as elucidation of
mechanisms of myelination. This system(s) could be used to determine efficacy of novel
therapeutics for demyelinating diseases such as Charcot-Marie Tooth, Guillian-Barre syndrome,
iii

anti-MAG peripheral neuropathy, as well as the testing of treatments for the regeneration of
damaged peripheral myelination from other causes.
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CHAPTER 1: INTRODUCTION
Schwann Cells Role in the Peripheral Nervous System & Myelination
You touch a hot pot, immediately you retract your hand as your brain tells your body
that it is hot. What allows you to react this quickly to this harmful stimulus? The answer is the
often-unsung hero of the peripheral nervous system (PNS), the Schwann cells.
Schwann cells are the predominant subtype of peripheral glia cells, and can be either
myelinating, or non-myelinating, both of which serve important purposes in the PNS [1, 2].
Glial cells of the PNS originate from Schwann cell precursors (SCPs) which are a derivation of
neural crest cells, cells that originate from the neural plate border, and may even be the oldest
version of these neural crest cells [3, 4]. There are many factors that lead to the neural crest
cell fate that allow them to be pluripotent, as well as migrate long distances in the body to the
specific areas where they are needed, including SOX9, PAX3, AP2α, and FOXD3 [4].
Transcription factor FOXD3 is responsible for directing the neural crest cells towards the glial
SCP direction rather than the neuronal direction, making it an essential factor for the
development of glial cells [5]. Various isoforms of neuregulin are expressed by axons in the PNS
at different timepoints and play important roles in the different stages of differentiation of
neural crest cells once they have reached the nerves of the PNS, and all the way into mature
Schwann cells [4]. Neural crest cells are not considered to be a part of the Schwann cell lineage
until they have travelled from the neural plate border to peripheral nerves and have associated
with them [4]. Once the neural crest cell has migrated, the cell differentiates into a Schwann
cell precursor (SCP), develops into an immature Schwann cell, and remains at this stage until
1

birth [6]. Once differentiated into SCPs, neuregulin-1 (NRG1) comes into play and helps the
cells retain their SCP identity [7]. NRG1 interacts with receptors that are found on SCPs, namely
ErbB2/3 receptors, and promotes survival of the SCPs [8]. Schwann cell precursors are found at
the edges and within embryonic nerves that have recently been formed, the SCPs surround
large groups of axons using extended sheet-like processes [9]. Schwann cell precursors have
been shown to be necessary for the survival of developing neurons through the expression of
signals that are key for the survival of the neurons [10]. Studies done involving the deletion of
these glial cells during the embryonic stage of development have shown that nerves that
extend to limb nerves die without the presence of these Schwann cell precursors [10]. As the
axons grow to their targets to form synapses during this embryonic stage, the SCPs differentiate
into immature Schwann cells. As this differentiation and nerve development is taking place, the
structure of the nerves changes, namely the axons are grouped into small bundles surrounded
by immature Schwann cells [9]. These immature Schwann cells then transition into one of two
mature Schwann cell types, either myelinating, or non-myelinating [10]. These bundles then
start to reduce in number as myelinating Schwann cells associated with single axons start to
separate selected axons from the bundles, this process is referred to as radial sorting [10].
One of the unique features of the Schwann cell lineage is the plasticity at different
stages of differentiation; most stages of differentiation are reversible depending on external
stimuli such as nerve injury meaning Schwann cells can also help with repair of nerves after
injury [10]. It has been shown that when nerves experience injury, both types of mature
Schwann cells, myelinating and non-myelinating can de-differentiate into a cell type similar to
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immature Schwann cells [11, 12]. Both myelinating and non-myelinating Schwann cells play
important roles in regards to survival and proper maintenance of neurons of the PNS. The main
regulator of which type of mature Schwann cell is formed is a secreted axonal signal, namely
type-III neuregulin 1 (NRG1-III) [1, 12]. While there are many isoforms of Neuregulin that are
involved in the various stages of the Schwann cell lineage, NRG1-III is secreted by axons and
involved with the directing of immature Schwann cells towards myelinating or non-myelinating
fates [1]. Axons with smaller diameters secrete lower amounts of NRG1-III and go through a
process called ensheathment where multiple small diameter axons are bundled together by a
single non-myelinating Schwann cell [1]. Non-myelinating Schwann cells express morphology
similar to that of immature Schwann cells.
While these non-myelinating Schwann cells don’t myelinate axons, they are still a very
important part of the peripheral nervous system, providing support as well as the potential to
repair damage done to the PNS. This class of Schwann cells serve various functions such as,
neuromuscular junction formation and maintenance where they are referred to as terminal
Schwann cells, acting as transducers at the ends of sensory neuron axons, and bundling small
non-myelinated motoneuron axons similar to the role of immature Schwann cells into
structures called Remak fibers [13]. While motoneuron axons are myelinated along the length
of the axon traveling to its target muscle fiber, the end of the axon when it reaches said muscle
fiber is unmyelinated, and forms a neuromuscular junction where it is protected by a small
population of non-myelinating Schwann cells known as terminal Schwann cells, or tSCs [13].
Muscle fibers will form cluster of acetylcholine receptors which are the targets for growing
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motoneuron axons where the neuromuscular junction is formed, and the tSCs have been
shown to play a part in the maturation of these acetylcholine clusters by releasing agrin, a
factor that has been shown to promote acetylcholine clustering on muscle fibers [14]. The tSCs
are typically found ahead of the growing axons, which advocates a role in the guidance of axons
to muscle fibers. Terminal Schwann cells have also been implicated in promoting proper
structure and function of the neuromuscular junction after it has been formed, as ablation of
tSCs in mice was shown to damage the neuromuscular junction [14]. The location of tSCs at the
synapse, in addition to the fact that they have neurotransmitter receptors both purinergic and
muscarinic, is reminiscent of astrocytes in the central nervous system, suggesting that these
tSCs might even play a role in regulating synaptic transmissions on top of formation and
maintenance of the neuromuscular junction. The tSCs extend processes into the synaptic cleft,
the area where neurotransmitters are released from the presynaptic terminal of the
motoneuron axon, further suggesting a role in modulating synaptic transmission to the muscle
[13]. Another important function of tSCs is selecting the best axon-muscle fiber during
neuromuscular junction formation. During development axons will have multiple axon
branches that go to the same muscle endplate, meaning the same muscle fiber will be
innervated by multiple competing axonal branches. The tSCs will select a single axon branch to
remain at the synapse and eliminate the other branches by causing them to withdraw to ensure
the best connection is formed. Once the extra “losing” axons are withdrawn, they fragment
into small pieces called axosomes which are then taken up by the cytoplasm of the Schwann
cell [13]. The process of this axonal selection is still not fully understood, and an in vitro model
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of myelination could potentially be an important tool to examine and further understand how
this process works.
In addition to supporting neuromuscular junction formation, Schwann cells have also
been implicated in the process of pain sensation by sensory afferent neurons in the PNS,
nociceptors. Studies have revealed the presence of Schwann cells in the dermis, specifically in
the border between dermis and epidermis, termed nociceptive Schwann cells (nSCs) that
closely interact with ascending nerve fibers. The bare unmyelinated nerve terminals emerge
through the Schwann cell bodies a few microns away from the epidermal border, with the
Schwann cells being their only source of cytoplasmic sheaths [15]. Schwann cells ensheath
bundles of nerves as they ascend towards the skin, with the number of axons in the bundles
decreasing the closer they got to the skin. These bundles are reminiscent of the bundles of
motoneuron axons that immature Schwann cells form, but with nociceptive axons. The overall
structure of these cutaneous Schwann cell-nociceptive axon bundles is a mesh-like network at
the subepidermal border [15]. This relationship of nSCs and unmyelinated nerve endings is
seen in Meissner corpuscles, lanceolate endings, and nerve glia, but not in Merkel cells or
dorsal root ganglia and is somewhat similar to the relationship between unmyelinated
motoneuron nerve endings and tSCs seen in the neuromuscular junction. In a study done with
mice, Schwann cells that were made sensitive to light via recombination were seen to be able
to produce a pain response without direct stimulation of the nociceptors [15]. As this is a
relatively recent discovery, there is still much to be understood about nSCs and their role in
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pain sensation. Further studies using a human in vitro nSC model could help elucidate their role
in pain sensation.
The observation that non-myelinating Schwann cells drive the formation of bundles of
small diameter axons of motoneurons and nociceptors was discovered by Robert Remak in
1838 [16]. These bundles are called Remak fibers and are made up of small axons with
diameters between 0.5 and 1.5µm which include not only C fiber nociceptors as mentioned
previously, but also pre and post sympathetic ganglionic fibers and preganglionic
parasympathetic fibers [13]. The Remak Schwann cells contact each other along the length of
the same Remak fiber and form junctions where they can communicate with each other. The
number of axons that make up a Remak fiber vary depending on the location of the region of
the nerve. The dorsal root near the ganglion has a higher ratio of Remak Schwann cells to
axons compared to where the same fiber enters the spinal cord [17]. This is a similar
morphology to the nSC-nociceptor relationship mentioned before, where the number of
nociceptive axons bundled by nociceptive Schwann cells decreases as the fiber gets closer to
the skin. While myelinated axons offer support to stabilize formed connections, the lack of
myelination in these Remak fibers grants the axons in the Remak fibers a level of plasticity that
is reduced when axons are myelinated. This plasticity specifically allows the ability for axons to
branch and grow which assists in repair in response to injury and changing environments [13].
Taking nociceptors as an example, partial denervation of skin can cause sprouting of the
nociceptive C fibers in neighboring areas towards the injured area to restore sensation [18]. In
motoneurons, these Remak fibers are an important step in a process known as radial sorting.
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Immature Schwann cells will extend processes into the axonal bundle where they recognize
large caliber axons and segregate them towards the periphery while the smaller axons will
remain bundled by Schwann cells which will differentiate to Remak Schwann cells [16]. While it
is understood that radial sorting is the process by which axons are selected to either myelinate
or form Remak fibers, the molecular factors that control it are still an area that is not fully
understood, which is where yet again an established in vitro model of human myelination could
be useful for elucidation.
One of the directing signals that has been established is the axonal signaling of Schwann
cells via Type III neuregulin 1. There are 4 isoforms of neuregulin that have been identified,
each type playing roles in different areas of the body including but not limited to, the breast,
heart, and nervous system [19]. Type III neuregulin (NRG1-III) has been shown to play an
important role in the differentiation of neural crest progenitors to Schwann cells by acting as a
juxtracrine signaling molecule, as well as a signaling molecule to determine the ensheathment
of axons by Schwann cells [19, 20]. Axons with diameters greater than 1 µm secrete NRG1-III at
high levels, which promotes the formation of a 1:1 myelinating Schwann cell to axon structure
[1, 8]. This makes sense, as one of the essential functions of myelinating Schwann cells is to
myelinate axons of the PNS in order to accelerate the transmission of action potentials along
the axon, so through the process of radial sorting, the thicker axons which are already going to
have a conduction velocity greater than those axons with diameters less than 1µm, will have an
even quicker rate of conduction due to the formation of myelin segments and nodes of Ranvier
[21]. The smaller axons will secrete less of this NRG1-III which drives them towards forming
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Remak fibers rather than the 1:1 Schwann cell-axon structure of myelination. Laminin and the
β1 integrin have been found to be essential factors that must be present for this radial sorting
to properly occur, the absence of either of these lead to improper myelination [22, 23].
Experiments done in mice with the β1 integrin inactivated showed improper radial sorting of
axons for the most part with some Schwann cells still managing to myelinate axons; these
findings tell us that the presence of other laminin receptors might still promote myelination to
a certain degree [23]. The β1 integrin most likely helps promote interaction between the basal
lamina laminin and cytoskeleton allowing ensheathment of axons by Schwann cells [23]. The
proper formation of the basal lamina is an essential requirement for proper myelination.
Ascorbic acid has been shown to be an important factor in the regulation and proper formation
of the basal lamina [24]. In early studies of myelination, chick embryo extract (EE) was included
in the myelination medium in rat co-cultures. When cultures were done without chick EE,
Schwann cells did not express the elongated phenotype of myelinating Schwann cells, however
when chick EE was supplemented in the medium, the SCs were seen to elongate along axons.
Basal lamina formation in the medium without chick EE was seen to have laminin formation as
well as heparan sulfate proteoglycan of basal lamina, the proper linear arrangement of these
factors was not observed. When chick EE was supplemented, the presence of laminin and
heparan sulfate proteoglycan was observed in the proper linear arrangement. Cultures grown
in medium containing chick EE treated with ascorbic acid oxidase, which should block the
effects of ascorbic acid, saw improper formation of the basal lamina, leading to the conclusion
that ascorbic acid is the component of chick EE that was directing proper basal lamina
formation [24]. When cultures were grown in medium without chick EE but supplemented with
8

ascorbic acid, proper basal lamina formation was seen, confirming the finding that ascorbic acid
plays an important role in proper basal lamina formation, which in turn allows proper
myelination to take place [24]. This is an important finding in the field of myelination, and
pretty much every in vitro model of myelination developed since then has relied on ascorbic
acid addition to promote proper myelination.
While certain signals such as NRG1-III need to be activated to promote myelination,
other signals that suppress myelination differentiation in immature Schwann cells must be
inactivated when myelination begins. These signals include c-Jun-amino (N)-terminal kinase or
JNK pathway, Notch signaling, and transcription factors PAX3 and SOX2, which are inactivated
once myelination begins. The transcription factor KROX20 is the major signaling factor that
causes this JNK suppression making it an essential step in the process of myelination [10].
Notch normally promotes proliferation of immature Schwann cells, as well as PAX3 and SOX2.
If these signals are not suppressed, they can inhibit proper myelination from taking place [10].
As the exact mechanisms that initiate myelination and suppress myelination inhibitory
pathways are not fully defined yet, an in vitro model of human myelination could be a useful
tool for the elucidation of these mechanisms.
The two main functions of glial cells (myelinating and non-myelinating Schwann cells)
are to offer support to axons and formed synapses, and increase the conduction speed of
action potentials along axons. Myelin sheaths are a multilayered extension of Schwann cell
membrane that tightly ensheath axon surfaces [25]. This multi layered membrane is referred to
as myelin, and is comprised mostly of a small number of different proteins which make up
9

about 15-30% of its total composition, and 70-85% lipids [26, 27]. The myelin found in the PNS
is compact, versus the non-compact myelin found in the central nervous system, with myelin in
the PNS only having extracellular space of about 2nm. The inner membrane of the myelin
sheath is negatively charged, and is in very close contact with the proteins found in the small
amount of cytoplasm that is present. In addition to these properties, the myelin sheath has
also been found to be augmented with zinc, and many of the proteins present in myelin bind to
zinc ions, suggesting that the zinc has some function in the formation of this compact myelin
structure [26]. The proteins present in myelin are often used as a means to show the
occurrence of myelination via immunocytochemistry in a number of myelination studies,
specifically proteins such as myelin protein 0 (P0), peripheral myelin protein 22 (PMP22), myelin
associated glycoprotein (MAG), and one of the most commonly used ,myelin basic protein
(MBP) [26]. As far as the lipid content is concerned, galactosylceramide or cerebroside is
considered to be the most common lipid found in myelin [27]. While the lipid content is not as
widely used as the myelin specific proteins when it comes to visualizing or detecting
myelination, it was an important part of our study when it came to using 3D confocal Raman
microscopy to detect the presence of myelinated axons which will be discussed in greater detail
later on.
Clustering of voltage gated sodium channels occurs in between the small spaces
between myelin sheaths, which are called nodes of Ranvier [21]. This myelin sheath-nodemyelin sheath-node, etc structure allows action potentials to “jump” from node to node rather
than travel directly through or along the axon, greatly increasing the rate at which the action
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potential travels from the motoneuron cell body to its target synapse [21]. First described by
Louis Antoine Ranvier in 1878, nodes of Ranvier consist of an internode region, followed by a
paranode, and then the node itself [21, 28]. The internode which is found right at the end of
the myelin segment consists of an outer collar of cytoplasm right under the basal lamina,
underneath the cytoplasm collar is a layer of compacted myelin, and then finally under the
compact myelin and right above the axolemma is an inner collar of cytoplasm. The paranode is
the next region that follows the internode but precedes the node itself, and is characterized by
thickened axolemma to create a septate-like junction, which is where the myelin sheath is
anchored to the axon. The node itself is an uncovered area of the axon in between sequential
myelin segments, where microvilli from the Schwann cells come in contact with a dense
cytoskeletal undercoating [21]. Potassium channels Kv1.2 and Kv1.2 are found on the
axolemma in the paranode, sodium channel clusters are found on the axolemma of the node,
and potassium channel Kv1.5 is found on the abaxonal outer collar of the Schwann cell above
the Schwann cell microvilli in the node [21]. This organization of clustered potassium and
sodium channels very different compared to the more diffused or spread out organization of
the same channels in unmyelinated axons [29]. The paranodal region consists of localized
proteins such as E-cadhedrin for cell adhesion of Schwann cells to the axon, connexin 32 which
has been hypothesized to play a role in the passage of potassium and other signal molecules
across the myelin sheath, as well as in promoting the cellular propagation of calcium signaling
through ATP release mechanism, myelin associated glycoprotein, and cytoskeletal proteins
spectrin and actin [30, 31]. In the node itself, voltage gated sodium channels and ankyrin are
found to be highly concentrated, with the sodium channels being almost 40x as concentrated
11

compared to internodal membranes [31]. Ankyrin is a specific isoform of proteins that bind to
spectrin using membrane binding domains using integral proteins such as ion channels, calcium
release channels, and cell adhesion molecules [31]. In the node highly concentrated ankyrin is
found in the form of a plaque-like material on the axolemma, and participates in the formation
of a structure that includes voltage gated sodium channels and actin/spectrin networks, with
two distinctly identified protein binding sites which leads to the belief that two voltage gated
sodium channels could bind to it, or one sodium channel along with another ankyrin binding
protein such as neurofascin, NrCAM, L1 adhesion molecule or NgCAM in vertebrates [31]. In
addition to binding these proteins to the axolemma, ankyrin may also play a role in stabilizing
proteins that have been clustered through other mechanisms [21]. So how do axons determine
where and when clusters of voltage gated sodium channels occur? Studies have shown that
Schwann cells must be interacting with and start ensheathing axons in order for the clustering
of voltage gated sodium channels to occur. During the early stages of Schwann cell and axon
interactions, adhesion molecules L1 and NCAM are seen to be highly expressed with little to no
myelin associated glycoprotein (MAG) expression, however as the Schwann cell-axon
interaction progress and a 1:1 relationship of Schwann cell to axon starts to form, expression of
these two molecules decrease, and expression of MAG increased. As MAG expression
increases, increasing clustering of the voltage gated sodium channels occurs after a slight delay,
suggesting MAG expression is one of the key markers in the development of myelination and
node formation [32].
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Past Models of Myelination
As a means to understand the process of myelination in greater detail, various models
of myelination have been established using animal cells, primary human cells, as well as a
combination of both. In this section we will review some of these previously established
models as well as their significance. One of the earliest methods to model myelination in vitro
relies on the disassociation of dorsal root ganglia (DRG) and postnatal Schwann cells from rats,
and then culturing them on coverslips. Patrick Wood et al made use of this method of
preparing a myelinating culture to study the initiation of myelination by Schwann cells [33].
They prepared their in vitro myelination model by disassociating dorsal root ganglia from rats
and then plating the cells onto a collagen coated coverslip. Once plated, the DRGs were fed
with medium containing antimitotic factor fluorodeoxyuridine. The purpose of the antimitotic
factor is to purify the neuronal culture, allowing addition of Schwann cells at a later point to
study how myelination is initiated by the newly added Schwann cells. After about 3 weeks in
the antimitotic medium, the pure neuronal culture is switched to serum containing medium
with no anti-mitotic factor included. At this point, Schwann cells are added to the culture in a
serum containing medium, and allowed to proliferate for 1-2 weeks and formed tight
relationships with the axons but no myelination was seen to occur. Once the culture is fully
repopulated, they are continued to be fed with serum containing medium with the addition of
ascorbate for 6-10 days to induce myelination [33]. Before ascorbate is introduced to the
culture, the axonal mitogens cause proliferation of Schwann cells at a high rate for several
weeks. The Schwann cells during the non-ascorbate stage were seen to sit on the outside of
axon fascicles or bundles, but did not surround axons or form a 1:1 Schwann cell to axon
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structure indicative of myelination. Once the serum containing medium is supplemented with
ascorbate, the Schwann cell morphology starts to change and develop into an elongated
phenotype, and proliferation of the Schwann cells starts to decrease. Basal lamina formation is
not possible without ascorbate, explaining why the ascorbate free medium did not lead to
myelination. After ascorbate is introduced, Schwann cell processes ensheathed axon bundles,
and multiple 1:1 Schwann cell to axon areas are observed, and within 4 days myelin sheath
formation is observed. The maturing of the Schwann cells at this stage is attributed to the
increasing formation of basal lamina on the Schwann cells as a result of the ascorbate, and is
seen at the highest degrees on myelinating Schwann cells. The basal lamina formation is
visualized via the immunostaining of laminin, heparan sulfate proteoglycan, and type 4 collagen
[33]. Laminin and heparan sulfate proteoglycan are expressed in low amounts in ascorbate free
conditions, with no detectable type 4 collagen, whereas all three are strongly expressed in the
ascorbate containing condition. They also found that the formation of Remak fibers of small
diameter and non-myelinating Schwann cells occurs slowly in conditions that promote
extensive myelination of larger axons suggesting a factor needed for this Remak fiber formation
is missing in their serum and ascorbate containing medium [33]. In previous work the authors
had established that myelin lipid galactocerebroside (GalC) and L1 adhesion molecule play
important roles in the initiation of myelination, and GalC expression is regulated by contact
with axons. In ascorbate free conditions, the majority of Schwann cells expressed GalC and
myelin associated glycoprotein (MAG), but expression of P0 and MBP was absent. Previous
studies had shown that the expression of GalC and MAG is dependent on the presence of
neurons, and the removal of neurons from Schwan cell cultures results in loss of expression of
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both, solidifying the belief that neuronal surface signals regulate the onset of myelination [33].
The fact that Schwann cells were expressing GalC and MAG in non-myelinating ascorbate free
conditions suggest that the presence of neurons alone non-specifically causes activation of
Schwann cells. Once ascorbate is added to induce myelination, the number of Schwann cells
expressed GalC and MAG decreased, and expression remained only in Schwann cells actively
forming myelin sheaths. At this point after some delay MBP and P 0 expression is seen in
myelinating Schwann cells, expression of which was non-existent in the ascorbate free nonmyelinating culture. These findings suggest that the stages of myelin sheath growth are
regulated by signals separate from those that upregulate GalC and MAG in the stages of
myelination initiation. The L1 adhesion molecule was seen to be strongly expressed along
axons, and weakly in Schwann cells. Blocking of L1 using anti-L1 antibody exhibited no
myelination even in the presence of ascorbate, and those cultures resembled those of the
ascorbate free non-myelinating cultures, but basal lamina deposition was still seen [33]. This
suggests that blocking of L1 prevents abaxonal interaction with the basal lamina, and that L1 is
a crucial signal when it comes to the elongation of Schwann cells along axonal surfaces, but not
exclusively involved in adhesion of Schwann cells to axons. When anti-GalC antibodies are
added to the culture, P0 and MBP expression was reduced, but MAG was not, implying that GalC
plays a role in maturation of myelin sheaths, but not in the initiation of myelination [33].
Another method of modeling myelination is using mouse DRGs instead of rat. In work
described by Satu Päiväläinen et al, a model utilizing pre-purified mouse embryonic DRG and
neonatal Schwann cells is validated. This model confers an advantage because by using
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neonatal Schwann cells, models with cell type specific and mixed genotype cocultures can be
established allowing a mixed coculture where cells from mutant animals can be added to cells
from wild type animals, allowing modeling of disease states and effects of cell type specific
mutations without having to cross breed the animals [34]. Rat PNS mutants are scarce however
mice already have many spontaneous and bioengineered mutations. DRGs were isolated by
dissecting spinal cords of 14-day old CD-1 mouse embryos, and grown using DRG growth
medium, and purified using DRG purification medium. Schwann cells were obtained by
dissecting and shredding sciatic nerves from 4 day old mouse pups, and purified .Cocultures
were then established by adding 50,000 Schwann cells to DRG cultures in DRG growth medium
and left to attach overnight, maintained in differentiation medium for 7-10 days, then switched
to myelination medium for 12-42 days [34]. Matrigel, a laminin-based gel, was shown to
promote better attachment and growth of DRGs and Schwann cells compared to thin layer
collagen or poly-L-lysine coatings which are typically used in rat myelination cocultures, so it
was the coating used in all subsequent experiments. The CD-1 mouse myelination cocultures
were compared to rat DRG derived cocultures, and a few different factors were required for the
mouse model to exhibit myelination at the same level as the rat cocultures. N2 supplement,
forskolin, and pituitary extract had to be added to typical rat myelination medium to achieve
robust myelination in the mouse cocultures. In addition to these factors, reducing the amount
of horse serum used from 15% to 5% increased myelination by 2.5-5x [34]. Through
immunocytochemistry, robust expression of MAG and MBP were seen in mouse myelination
medium cultures. Comparison of mouse and rat myelinating cultures showed close similarity in
the stages of myelination taking place in both systems. Initially when Schwann cells first started
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interacting with axons, MAG expression was seen uniformly throughout the Schwann cell as a
whole, then when the Schwann cells start to envelop axons, MAG expression localized in the
mesaxonal spiral around the axon, and finally during the myelin compaction stage, MAG
expression concentrates in band like structures at intervals along the length of the sheath as
well as the paranodal regions. The mouse cocultures exhibited similar levels of mature myelin
sheaths when compared to the rat cocultures [34]. Next, coculture using C57BL6 mice was
established using the same methods/conditions as the CD-1 mouse cocultures. Again, using
MAG and MBP as markers of myelination, high levels of myelination were observed in this
alternate strain of mouse. The successful myelination seen in this alternate strain of mouse
proves the ability to use mutant mice as a source of cells to create mixed genotype cocultures
to study effects of cell specific mutations or combination of mutations without having to cross
breed them [34].
Another model done by Liazoghli et al also makes use of rat DRG derived cells, however
they use a patterned surface to direct axonal growth, making the myelinating Schwann cells
more physically accessible which could provide an advantage when it comes to studying
physical structure of myelinating Schwann cells and myelinated axons [35]. Using a
microprinted PDMS “stamp” of a line pattern, authors were able to dip the PDMS structure in
Matrigel, and then stamp the line pattern onto a glass coverslip to give a patterned coverslip
with Matrigel lines of 10µm with intervals of 110µm in between the lines treated with PLL-gPEG which is a substrate that is non-conducive for cell adhesion. With this surface
modification, they found that both Schwann cells and neuron axons grew only in the patterned
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Matrigel lines [35]. Once the surfaces were patterned, rat DRGs were dissected from E15-E16
embryos, and plated onto the substrates. The Schwann cells and neurons were both sourced
from the same DRG, rather than extracting the cells from two different sources and adding the
Schwann cells exogenously. After 7 days of culture on the patterned surfaces, they were
visualized using immunocytochemistry, and it was observed that the axons grew only along the
Matrigel lines, and the endogenous Schwann cells migrated along the lines/axons and tightly
associated with the axons. Ascorbic acid was added at this point for 6 weeks in order to initiate
myelination, which was successfully observed in the form of compact myelin separated by small
unmyelinated spaces of the internode, again by immunocytochemistry using antibodies for
neurofilament and myelin basic protein after 6 weeks. Further staining done using Caspr and
neurofilament indicated formation of nodes of Ranvier, a trademark characteristic of
myelination [35]. The advantage of this system over the previously described models of
myelination, is the patterning which could allow better examination of the process of
myelination over time, for example one could monitor the same axon over time by looking at
the same “line” each time, making it easy to find the same axon for repeat observation. While
this specific study utilizes rat DRGs, this concept could be used with other cell types as well
including mice or even human cells.
While multiple rat and mouse myelination models have been established, most of them
utilize serum in their medium formulation. While serum is conducive for cell growth and
development, the lack of information about the exact factors and components that make it up
could make elucidation of factors that benefit or control myelination is more difficult. Work
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done by Rumsey et al describes an in vitro model of myelination using rat motoneurons and
Schwann cells, in a defined, serum free myelination medium [36]. Schwann cell-motoneuron
co-cultures were done on surfaces modified with N-1[3 (trimethoxysilyl) propyl]
diethylenetriamine (DETA), which is a non-biological self-assembles into a polymer that is
biomimetic. The advantage of using such a surface coating is that since it is non-biological it
cannot be degraded by cells, and makes it easier to identify extracellular matrix factors
produced by the cells which could be an important step when it comes to figuring out exactly
what goes on during myelination in terms of extracellular matrix production. The serum free
medium also confers an advantage as well when it comes to defining what role certain factors
play in the myelination process. For example, one could remove a factor from the medium that
is known to successfully promote myelination, and then analyze the effects if any that occur
due to its removal. Something like this would not be possible in a system utilizing serum which
contains a mix of unidentified factors. The system exhibited both the formation of myelin
sheaths via immunocytochemistry staining of Neurofilament and MBP, as well as node of
Ranvier formation using markers for paranodal protein Caspr, and voltage gated sodium
channels PAN. This study also quantified the efficiency of myelination by counting the number
of myelin segments formed relative to axons, and was shown to be around 63% [36]. This
quantitative value is a metric that could be looked at in response to removal or addition of
factors from or to the defined medium, to see if said factors increase or decrease the amount of
myelination seen in the system and by how much.
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One of the applications that an in vitro model of myelination could allow is the testing of
drugs or factors and the effect it can have on myelination. In a study done by Sujin Hyung et al,
a myelinating co-culture using mice, the effects of treatment by coenzyme Q10 and riluzole
were examined [37]. Coenzyme Q10 is an enzyme that plays a role in oxidative phosphorylation
in mitochondria, converting carbohydrate derived energy into ATP to drive cellular processes
and cell synthesis [38]. Riluzole is a drug that has been suggested to improve neuronal health
of axons by decreasing levels of glutamate and has been used in the treatment of ALS [37]. To
establish their myelination model, Schwann cells were derived from sciatic nerves of Day 4
postnatal mice and grown on a 3mm layer of Matrigel. Motoneurons were collected from
ventral horns of Day 14 embryonic mice and added onto the layer of Schwann cells after 7 days
of allowing the Schwann cells to proliferate and form a confluents monolayer. Axonal length in
response to the presence of Schwann cells was examined and it was seen that axon length after
2 days was 4 times longer in the presence of Schwann cells as opposed to motoneuron
monocultures, suggesting that Schwann cells are an important factor in survival and growth of
motoneurons. Myelination was confirmed via immunocytochemistry through the use of
Schwann cells markers Sox10, and transcriptional factor controlling myelination, and MBP, with
TuJ1 being used to visualize axons. Myelin sheath formation and compaction was observed
over the course of 21 days, with MBP expression increasing from none at Day 7, to forming
compact sheaths along axons at Day 21. Myelination was further confirmed through the use of
transmission electron microscopy, which showed loose wrapping of myelin around axons at Day
14 suggesting the premyelinating stage, and compaction of the sheath by Day 21 with a
thickness of .2µm [37]. Western blot analysis done using MBP and Krox20 another marker of
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myelination showed a marked increase in the presence of these markers over the course of 21
days. Co-cultures were then established and treated with coenzyme Q10 and riluzole. When
control, coenzyme Q10 treated, and riluzole treated cultures were compared, the coenzyme
Q10 cultures exhibited presence of myelinating Schwann cells via MBP expression at Day 7
while the other two conditions did not. At day 14 all three conditions exhibited the presence of
myelinating Schwann cells, but the amount of them was higher in the coenzyme Q10 condition.
By Day 21 all the conditions had MBP expression suggesting that Schwann cell differentiation to
their myelinating stage properly takes place in their established system. While the riluzole was
seen to have no effect in myelination, the coenzyme Q10 showed increased MBP expression at
earlier stages where the other two conditions did not, suggesting that it increased the rate at
which axons were myelinated. Motoneurons appear to have higher energy needs, so it makes
sense that coenzyme Q10 could increase the rate of myelination by increasing the amount of
ATP that can be synthesized in its presence, as well as acting as an antioxidant, making it an
interesting point of future investigation into the exact mechanism and efficiency of the enzyme
related to myelination [37]. This works highlights the ability of an in vitro model as a tool to
study efficacy of drugs that could potentially increase myelination to combat demyelination by
either disease or injury.
While many models of myelination using rat or mouse cells have been established,
translatability of animal models to humans is often poor, and offer limited predictability of
safety, toxicity, and effects of chemical entities in humans [39]. In order to combat this, the
establishment of a myelination model using human motoneurons and Schwann cells is a
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growing area of interest. In work done by Anup D. Sharma et al, they fabricate a 3D spheroid
model of a peripheral nerve using both human motoneurons and primary human Schwann cells
[40]. Using iCell® motoneurons and human primary Schwann cells, a spheroid was constructed
in a U-shaped round bottom spheroid microplate, and then transferred into a 3D dual hydrogel
construct to imitate peripheral nerve structure, with a Schwann cell to motoneuron ratio
optimized to create the largest possible spheroid to fit in their dual hydrogel nerve on a chip
construct. The nerve construct consisted of a round bulb structure where the spheroid was
plated, with a tract coming out of the bulb for axons to grow through and Schwann cells to
migrate along the axons [40]. The spheroid was cultured in a medium containing 10% fetal
bovine serum for a week, at which point the medium was supplemented with NGF and ascorbic
acid to promote axon growth and myelination respectively. Characterization of myelination
was done using immunocytochemistry, transmission electron microscopy, and
electrophysiological data was collected with a set of two concentric bipolar platinum-iridium
electrodes. Immunocytochemistry was done using βIII-tubulin to visualize axons, and S100b to
visualize Schwann cell migration and elongation along axons. Over the course of 4 weeks,
axons bundles were seen growing out of the bulb into the tract at a rate of ~1mm per week,
with S100b positive Schwann cells bodies migrating out of the bulb and interacting with some
of the axons in the bundle. They observed that cultures where basal medium that did not
include the fetal bovine serum did not facilitate migration and myelination by the Schwann
cells. The nerve structure after 4 weeks was embedded in plastic resin and sectioned to
perform analysis by transmission electron microscopy. The TEM of the bulb section revealed
the presence of both motoneuron and Schwann cell bodies, while TEM of the tract section
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showed only axons and Schwann cell bodies, confirming that only Schwann cell bodies were
migrating into the tract and not motoneuron cell bodies. Myelination in various stages was
observed, namely non-compact myelin, myelin in the process of compacting, and compacted
myelin. Electrophysiological data was collected by sticking one electrode in the tract ~1-3mm
away from the cell bodies, and another electrode at the cell bodies. The electrode in the axonal
tract was stimulated, and the distance and speed of the impulse to the other electrode was
recorded. While myelination is supposed to increase the speed of action potential conduction,
they saw that the co-cultures exhibited a slower rate of conduction as compared to
motoneuron monocultures [40]. Since this system utilized a bundle of axons instead of
individual axons, this lack of increase in the rate of conductance could possibly be due to the
presence of unmyelinated or partially myelinated axons present in the bundle. While the
establishment of a human cell-based model of myelination is a significant progression in the
area of in vitro myelination models, addressing certain limitations of this model can greatly
improve the usefulness of such a model. One of these limitations is the use of a serum
containing medium. As discussed previously in this section, analyzing exact factors and their
effects on myelination is limited in a serum-based system, as serum contains a multitude of
undefined factors. Being able to selectively examine the effects of specific factors can go much
further in terms of elucidating exact mechanisms taking place during myelination. Also, using a
spheroid construct with bundle of axons while it may more accurately mimic in vivo structures,
makes it difficult to look at single axon fibers and how Schwann cells interact with them.
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Overall these studies are an example of how in vitro animal models can be used to
elucidate mechanisms that control myelination, as well as the ability to recreate myelination in
vitro using human cells for accurate translatability. The developed model we will discuss in this
work utilizes iPSC derived human motoneurons and primary Schwann cells as well as some data
utilizing iPSC derived Schwann cells, in a defined, serum free medium, allowing further
investigation of the effects of removing or adding specific factors on myelination in humans.

Characterization Methods of Myelination
This section contains background information regarding commonly used methods to
characterize myelination in vitro, as well as background information about 3D confocal Raman
microscopy, which is presented as a potentially novel method for myelination characterization
in vitro in our work.
Immunocytochemistry (ICC) is the most widely used and accepted method of
characterizing myelination in vitro and is a standard in almost all studies done relating to in
vitro myelination [33-37, 40-44]. Utilizing antibody-antigen binding, this method can be used to
specifically identify target proteins or antigens, which can then be visualized with a secondary
fluorescent antibody and fluorescence microscope. Simply, this process works by introducing a
primary antibody specific to the antigen one wishes to identify, the antibody then binds to the
target antigen, after which a secondary antibody specific for the primary antibody is introduced
and binds to the primary antibody. The secondary antibody will be conjugated with a
wavelength specific fluorescent molecule which emits light when exposed to the specific
wavelength, allowing visualization of the target antigen. Antibodies are a part of the adaptive
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immune system, and function by detecting and binding to foreign substances in the body for
removal. Binding of antibodies to antigens is specific and therefore can be used to distinguish
the target antigen from other antigens that are present. Antibodies are immunoglobulins
produced by B cells when a foreign antigen is detected. Out of the 5 classes of
immunoglobulins, type G (IgG) has the longest half-life in serum, making it the ideal
immunoglobulin type for the purpose of ICC [45]. Antibodies are made of two distinct regions,
the Fab region and Fc region. The Fab region consists of two arms, each arm is made up of one
variable light chain, one variable heavy chain, one constant heavy chain, and one constant light
chain, with the variable chains at the end acting as the antigen binding sites. The two arms of
the Fab region are connected to a single arm of the Fc region consisting of 4 constant heavy
chain regions via disulfide bonds, creating an overall structure in the shape of a “Y” [45]. The
Fab region will bind to the target specific antigen, with the Fc region exposed, where the
secondary fluorescent antibody will bind. Once the antibody specific for a target antigen has
been identified and purified it can be used to target the antigen for identification in various
characterization methods including but not limited to ICC, western blot analysis, and flow
cytometry. In terms of myelination, many antibodies for proteins found in myelin and axons
have been identified and well characterized, making antibodies for the purpose characterizing
myelination commercially available. Some of the antibodies frequently used for myelination
characterization include but are not limited to MBP, myelin protein zero, MAG, etc., many of
which have been mentioned in the previous section. The relative ease of using this method
combined with the commercial availability of specific antibodies has made ICC a gold standard
for characterizing myelination.
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Another potential method of characterizing the presence of myelination promoting
factors, is western blot analysis a method first developed in 1979 by Harry Towbin [46]. While
this method does not allow visualization of the location of the target protein or analysis, it does
allow one to detect the presence of a specific protein or antibody in a sample. Utilizing
antibodies in the same way ICC does, the presence of a protein is detecting by binding of the
primary antibody to the target antigen, which is then visualized as bands on a blot membrane.
While this is a mostly qualitative method, some quantitative information about the amount of
protein present can be determined by the size and intensity of the protein band. For use in
myelination studies, one could determine changes in expression of amount of myelination
specific proteins over time, making it a useful tool in determining which proteins are expressed
at different stages of myelination, as well as how much. While western blots alone typically are
not sufficient to determine myelination, combining data from a western blot with other
methods of characterization such as ICC could be a useful tool in determining degrees of
myelination specific expression.
Flow cytometry is another method that could be used to determine how many cells in a
population express a certain protein. Once again utilizing antibodies specific for a target
antigen, a large population of cells can be examined at once to determine what percentage of
them are positive for said target antigen. In our work, flow cytometry was utilized to determine
what percentage of Schwann cells exhibited the pro-myelinating stage in response to ascorbate
addition. Using Krox20, a marker for myelinating Schwann cells, flow cytometry was used to
compare the percentage of cells in the pro-myelinating stage in response to ascorbate with
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Schwann cells without any ascorbate treatment. While visualization of antigen expression is
not allowed by this method, it is an effective tool to quantitatively determine how many cells
express a specific antigen or protein.
Transmission electron microscopy (TEM) is another method that has often been used to
visualize myelin sheath formation. This technique doesn’t require antibodies at all, but relies
instead on electron interactions to create an image of an ultrathin sample. An ultrathin section
of a sample is taken and a beam of electrons is transmitted through the sample, and the
interactions of the electrons with the sample are sent to a sensor or fluorescent screen to
reveal the fine detail of the sample. The resolution of TEM is much higher than that of typical
light microscopes since the de Broglie wavelength of electrons is much smaller than that of
light. This allows TEM to be used to image detail of the sample at atomic levels. In myelination
studies, cross sections of a myelinated axons can be imaged to visualize myelin sheath
formation and compaction [40, 47]. While this is an attractive option for myelination
characterization, it is difficult to do on a 2D model such as myelination on a coverslip, as cross
sectioning such a small sample can be difficult.
3D confocal Raman microscopy is a relatively new method that relies on the Raman
effect, which is a principle stating that radiation emitted through a sample has different
frequencies than the incident radiation [48]. This method works by shining a monochromatic
laser through a sample, which then interacts with the molecular vibrations of molecules in the
sample. When the laser interacts with molecules in the sample, the light scatters in all
directions after interacting with the molecules. The majority of the scattered light is emitted at
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the same frequency as the incident light which is known as Rayleigh scattering, however a small
fraction of the scattered light has a frequency different than the incident light, and this
scattering is referred to as Raman scattering [48]. The frequency of the Raman scattered light
can then be used to create spectra where the wavelengths seen correlate to specific molecular
bond vibrations in a method called Raman spectroscopy. Combining Raman spectroscopy with
confocal microscopy gives rise to 3D confocal Raman microscopy, a method by which Raman
spectra can be used to create a 3D image based on the Raman spectra given by molecular
properties of certain areas of the sample. Using this method of characterization in biological
applications has allowed the ability to identify different cell types in tissues with great detail
[49-51]. Characteristic peaks relating to various specific cell types based on their molecular
have been identified making this a viable candidate for non-invasive characterization of
biological samples for various applications without the need for antibodies or staining [51]. In
terms of myelination, work has been done with Raman spectroscopy using ex vivo samples of
peripheral nerves and spinal cord tissue to elucidate signature peaks associated with axons of
peripheral nerves, and myelinated vs unmyelinated fibers [50, 52, 53]. Taking the work done
with Raman spectroscopy to examine ex vivo samples of peripheral nerves, we utilized the
signature peaks identified in these studies to perform 3D confocal Raman microscopy as a novel
method to confirm and visualize myelination in an in vitro model of myelination.
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Focus of Research
While many animal cell models of myelination, and one model using all human cells
have been established, much room to improve on these models remains [33-37, 40-44, 47].
Models of myelination have the potential to be used as a method of further investigation of the
exact mechanisms of myelination, mechanisms of demyelination due to disease or injury, as
well as offer a platform for the testing of drugs or therapeutics that are developed to combat
diseases and disorders that affect myelination. The poor translatability of data generated using
animal models to humans is an issue that must be addressed in order to make in vitro cell
culture systems an effective method of studying drug interactions in humans [54]. Models that
rely on the use of serum in their cultures confound studies investigating specific growth factors
relating to the process of myelination. Therefore, the development of a system with a culture
medium that does not contain serum and is fully defined in terms of components is a crucial
development in the area of in vitro modelling of myelination. Here we report the development
and characterization of a novel, fully human, serum free model of myelination utilizing primary
human Schwann cells, as well as work done furthering the model with iPSC derived Schwann
cells. We also report the use of 3D confocal Raman microscopy a novel characterization
method for visualizing myelination in an in vitro system.
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CHAPTER 2: MATERIALS AND METHODS
Surface Modification and Protein Coating
18mm round glass coverslips (Thomas Scientific, Swedesboro, NJ, USA) were plasma
cleaned for 20 minutes at 750µTor. The trimethoxysilylpropyldiethylenetri-amine (DETA,
T2910KG; United Chemical Technologies Inc., Bristol, PA, USA) film was formed by the reaction
of cleaned surfaces with a 0.1% (v/v) mixture of the organosilane in freshly distilled toluene
(T2904; Fisher, Suwanne, GA, USA). The DETA coated coverslips were heated to 90ᵒC, then
cooled to room temperature (RT), rinsed with toluene, reheated to approximately the same
temperature, and then cured for at least 2 hours at 110ᵒC. Surfaces were characterized by
contact angle and X-ray photoelectron spectroscopy as described previously [55]. Coverslips
were then incubated overnight in an entactin/collagen/laminin (ECL) solution to deposit the
extracellular matrix proteins on the DETA modified surface.

Human iPSC Motoneuron Culture
Human iPSCs (line ND41865) were obtained from the Coriell Institute for Medical
Research and denoted as passage 0 (P0). The cells were passaged up to P10 using NIH
recommended protocols. Cells from P6-10 were used for motoneuron (MN) differentiation.
MNs were differentiated from iPSCs by following previously published protocols with the
modification of replacing Component C with 0.1μM LDN193189 (Tocris #6053) and 6μM
SB431542 (Tocris #1614) [56]. Differentiated MNs were maintained in human motoneuron
medium (hMN) as previously described [57]. Vials of MNs were cryopreserved for use in future
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experiments. Following retrieval of MNs from cryostorage, the vial of cells was thawed in a
water bath with gentle swirling. The cells were transferred to a 50mL conical tube and 9mL of
cold PBS was added to the cells dropwise. The cells were pelleted at 250g for 5 minutes in a 4°C
centrifuge. The PBS was aspirated and the MNs were suspended in 1mL of hMN medium. A cell
count was performed. The cells were plated on 18mm round ECL-coated coverslips (Sigma
CLS284518) at 200 cells/mm2 suspended in 200µL of hMN medium for monoculture
experiements. The cultures were maintained in a 37°C, 5% CO2 incubator. The following day, a
full medium change was performed to remove non-adherent cells. A 50% medium change was
performed daily for the duration of the experiments.

Primary Human Schwann Cell Culture
Human primary SCs were cultured according to the vendor’s protocol (Sciencell 1700).
Briefly, cryopreserved SCs were thawed in a water bath with gentle swirling. The cells were
immediately transferred to a T-75 flask containing prewarmed Schwann cell medium (SCM)
(Sciencell 1701) and put into a 37°C, 5% CO2 incubator. The SCs were expanded and passaged
one time prior to use in experiments. For monoculture experiments, SCs were plated on ECLcoated 18mm round coverslips at 200 cells/mm2 suspended in 200µL of SC medium.

iPSC Schwann Cell Culture
Human iPSCs (line ND41865) were obtained from the Coriell Institute for Medical
Research and denoted as passage 0 (P0). iPSCs were passaged, and cells from P1-P2 were
differentiated into iPSC derived Schwann cells following the protocol established by Han-Seuop
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Kim et al [58]. Differentiated iPSC Schwann cells (iPSC-SCs) were maintained in Schwann cell
medium (SCM) (Sciencell 1701). Vials of iPSC SCs were cryopreserved for use in future
experiments. Following retrieval of iPSC SCs from cryostorage, the vial of cells was thawed in a
water bath with gentle swirling. The cells were transferred to a 50mL conical tube and 9mL of
cold SCM was added to the cells dropwise. The cells were pelleted at 290g for 5 minutes in a
4°C centrifuge. The SCM was aspirated and the iPSC-SCs were suspended in 1mL of SCM. A cell
count was performed. The cells were plated on 18mm round ECL-coated coverslips (Sigma
CLS284518) at 200 cells/mm2 suspended in 200µL of SCM for monoculture experiements. The
cultures were maintained in a 37°C, 5% CO2 incubator. The following day, a full medium change
was performed to remove non-adherent cells. A 50% medium change was performed daily for
the duration of the experiments.

iPSC Human Motoneurons and Primary Human Schwann Cell Co-Culture
Timeline of co-culture plating and maintenance is shown in Figure 1. MNs were plated
on 18 mm DETA modified, ECL coated coverslips (Day -7 in co-culture), at a density of 300
cells/mm2 and maintained in hMN medium for 7 days. After 7 days (Day 0 in co-culture),
human SCs were plated on top of the MN culture at a density of 200 cells/mm2, and the coculture was maintained in a 1:1 hMN to SC medium overnight until the SCs reached 80%
confluency, at which point the medium was switched to myelination medium (MM) containing:
1x Neurobasal, 1x B27, 1x GlutaMax, 1x antibiotic/antimitotic, 20ng/mL BDNF, 10ng/mL GDNF,
5ng/mL CNTF, 20ng/mL CT-1, 20ng/mL NT-3, 20ng/mL NT-4, 80ng/mL Heparan Sulfate,
100ng/mL vitronectin, 50 ng/mL SHH, 10ng/mL IGF-1, 1µM cAMP, and 270-280mOsm NaCl. A
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50% medium change was performed daily for the duration of the experiments with the addition
of 50µg/mL of ascorbate at each feeding starting at day 7 in co-culture.

Flow Cytometry
SCs were plated in two T-75 flasks in SCM. After reaching confluency, one flask was
switched to MM, and the other was maintained in the SCM, both flasks were fed with half
medium exchange every other day. Seven days after flasks were plated, ascorbate was added to
the MM flask at each medium change. At day 14, the cells from both flasks were lifted using
Accutase (Sigma A6964). An equal volume of FACS buffer, consisting of PBS+1%BSA, was used
to neutralize the accutase reaction after which the cells were collected in 50mL conical tubes
(one for each flask), and centrifuged for 5 minutes at 300g. The supernatant was aspirated and
the cell pellets were resuspended in 100uL of FACS buffer. Next, 100uL of PBS+0.2% saponin
was added to the cell suspension to permeabilize the cells. Cells were then pelleted at 300g for
5 minutes, and resuspended in 100uL of FACS buffer. 20uL Human FcR Block (Miltenyi Biotec)
was then added to each tube on ice to block the Fc receptors for 20 minutes. After blocking,
each tube of cells was split into 2 1.5uL microcentrifuge tubes, and 5uL of Egr2-PE and 5uL of
Draq7 were added to one of the two tubes from each condition, while the second tube for both
conditions was left unstained. All tubes were then left to incubate on ice for 60 minutes before
being washed with 200uL FACS buffer, then spun down for 5 minutes at 300g, and resuspended
in 120uL of FACS buffer. This washing was done two more times, then analyzed in the flow
cytometer.
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Immunocytochemistry and Confocal Microscopy Image Analysis
Co-cultures were fixed at day 31 with freshly prepared 4% paraformaldehyde in PBS for
15 minutes, then rinsed twice with PBS (pH 7.2, without Mg2+ and Ca2+). Next, they were
permeabilized with a 0.5% Triton X-100/PBS for 15 minutes at room temperature. Non-specific
binding sites were blocked with the permeabilization solution and Blocking Buffer (5% Donkey
serum plus 0.5% BSA in PBS) for one hour at room temperature. Co-cultures were incubated
with primary antibodies in blocking buffer at 4⁰C overnight. The following antibodies were
purchased; Anti-MBP (Millipore MAB382), Anti-NF-H (Millipore as5539), Anti-S100b (Thermo
Fisher 710363), Anti-PAN (Millipore AB5210a), and Anti-Caspr1 (Novus Biologicals AF7548). The
next day, the primary antibody/blocking buffer solution was removed, and the cells were rinsed
3x with PBS. Then AlexaFluor 488 nm, 568 nm, and 647 nm secondary antibodies were diluted
1:250 in blocking buffer, were added, and incubated at room temperature for 2 hours in the
dark. The secondary antibody/blocking buffer solution was removed, and cells were rinsed 3x
with PBS, then incubated for 5 minutes in a 1:1000 DAPI in PBS solution. After 5 minutes the
DAPI/PBS solution was removed and the cells were rinsed 3 times with PBS, before being
mounted onto glass slides using VectaShield mounting medium (Invitrogen P36931). Mounted
samples were imaged with either an Axioskop 2 mot plus upright spinning disk confocal
microscope (Carl Zeiss) or a Nikon Eclipse Ti2 inverted microscope. Fluorescence images were
collected using 10X, 40X, or 63X objectives and 10X magnification with the Axioskop 2
connected to an XCite 120 Fluorescence Illumination system (EXFO) beam, a multi-spectral
scanning laser utilizing Volocity software (Perkin Elmer), or a Nikon Eclipse Ti2 inverted
microscope connected to a C2 confocal controller utilizing NIS elements software.
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3D Confocal Raman Microscopy and Analysis
Cells were fixed with fresh 4⁰C 4% paraformaldehyde for 15 minutes, gently rinsed twice
with sterile water, then mounted face-up on glass slides to best preserve proteins in the sample
45. Raman spectroscopy measurements, and 3D confocal chemical maps were obtained on an
upright confocal Raman microscope, (WiTec Alpha 300 RA) with excitation wavelength of
532nm, and power set to 5.8mW. Light was focused on the sample and axons were located via
brightfield microscopy at 100x. A grating of 600 g/mm was used in the spectrometer, and
photocollection was performed using a CCD detector (Andor iDUS DV401A-BV-352) with an
integration time of 5s per spectrum. Raman spectroscopy was used to confirm the presence of
a myelinated axon via the presence of characteristic myelin protein and axonal Raman bands
23. Once identified, a volume (5µm wide, 5µm high, and 3.9µm deep) of the myelinated axon
was probed via a confocal Raman z-stack of 4 layers. Obtained spectra were processed by
performing background subtraction, Cosmic Ray Removal, and Savitzky-Golay smoothing in
Project FOUR (WITec). Resulting image stacks were used to construct 3D renderings using an
ImageJ plugin, Volume Viewer. For the 1665cm-1 reconstruction (Fig. 7F), lower intensity signal
areas were removed, and the model was rotated within Volume Viewer in order to highlight the
myelin sheath surrounding the axon track. The 1650cm-1, and 2960cm-1 reconstructions (Fig.
7D-F) were rotated but all signals are represented.
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Myelination Efficiency Quantification
Myelination efficiency was quantified as follows: #𝑚𝑦𝑒𝑙𝑖𝑛 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠/#𝑎𝑙𝑖𝑔𝑛𝑒𝑑
𝑆𝐶𝑠x100= Myelination Efficiency (%). The number of myelin segments per frame were counted
using the MBP and NF channel overlays, and the number of aligned SCs in the same frame were
counted using S100b, NF, and DAPI channel overlays from the same image. This was done with
5 coverslips from 3 different cultures.

iPSC Motoneuron and iPSC Schwann Cell Co-Culture
MNs and iPSC-SCs were plated on 18 mm DETA modified, ECL coated coverslips at the
same time, with MNs at a density of 300 cells/mm2 and iPSC-SCs at a density of 200 cells/mm2
in 50/50 hMN-SCM and were left in this combined medium overnight, after which cultures
were switched to myelination medium (MM) containing: 1x Neurobasal, 1x B27, 1x GlutaMax,
1x antibiotic/antimitotic, 20ng/mL BDNF, 10ng/mL GDNF, 5ng/mL CNTF, 20ng/mL CT-1,
20ng/mL NT-3, 20ng/mL NT-4, 80ng/mL Heparan Sulfate, 100ng/mL vitronectin, 50 ng/mL SHH,
10ng/mL IGF-1, 1µM cAMP, 20ng/mL NRG1-III, and 270-280mOsm NaCl. A 50% medium change
was performed daily for the duration of the experiments with the addition of 50µg/mL of
ascorbate at each feeding starting at day 7 in co-culture.
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CHAPTER 3: RESULTS
Characterization of iPSC Motoneuron and Schwann Cell (Primary and iPSC) Monocultures
Characterization of iPSC human motoneurons
iPSC-MNs, and both primary and iPSC derived human SCs were characterized before cocultures were established. By day 5 axonal outgrowth in the iPSC-MN culture was observed and
by day 14 what appeared to be mature axons were formed (Fig. 1A). Immunocytochemistry at
day 7 indicated MNs expressed two neuron-specific markers, microtubule associated protein 2
(MAP2) and neurofilament-heavy (NF-H) (Fig. 1B). Additionally, flow cytometry at day 7
revealed that 99.68% of MNs expressed Islet-1 and 99.81% of MNs expressed HB9, two
important motoneuron transcription factors [56] (Fig. 1C). Using Raman spectroscopy, the
chemical fingerprint of the system was obtained. Most notable, bands at ~1421cm-1 (C-H
deformation of lipids and proteins), 1650cm-1 (C=C stretch of amide I protein structure),
2876cm-1 (CH2 asymmetric stretch of lipids and proteins), 2915cm-1 (C-H stretch of proteins),
and lastly, 2998cm-1 (C-H stretching of lipids and fatty acids) were observed [51] (Fig. 1D). These
findings are in agreement with previous studies on in vivo spinal cord samples, which
established the motoneuron Raman signature [59] (Fig. 1D).
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Figure 1: Characterization of human iPSC-derived motoneurons in monoculture A) phase
contrast microscopy of motoneurons (MNs) at day 5 (left) and day 14 (right), B) confocal
microscopy of MNs indicating expression of structural proteins neurofilament (NF) and
microtubule associated protein 2 (MAP2), Scale bars = 50µm. C) percentage of MNs expressing
transcription factors Islet-1 (left) and HB9 (right), D) Raman spectra for unmyelinated axons.
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Characterization of human primary Schwann cells
By day 7 SCs formed a monolayer and some cells began to exhibit the characteristic
spindle-like morphology via phase microscopy (Fig. 2A). Additionally, SCs stained positive for
S100b, a characteristic calcium binding protein expressed by SCs (Fig. 2B). Data was confirmed
by flow cytometry, where 89.06% of cells expressed S100b (Fig. 2C). Notably, EGR2/Krox20
expression, which marks myelinating SCs specifically, was observed in 41.61% of the SCs when
cultured in the myelination medium (Fig. 2C). Raman identified particular bands of interest at
2862cm-1 (CH2 symmetric stretch of lipids), 2933cm-1 (CH2 asymmetric stretch), 2970cm-1 (CH3
asymmetric stretch of lipids and fatty acids), and 3010cm-1 (Unsaturated =CH stretch of
lipids)[51]. These bands are primarily found between 2800-3000cm-1, due to the high lipid
content in the SC monocultures [52] (Fig. 2D).
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Figure 2: Characterization of biopsy-derived human SC in monoculture A) phase contrast
microscopy of SCs at day 7 B) confocal microscopy of SCs plated at lower density to show SC
morphology, indicating expression of calcium binding protein S100b, Scale bars = 50µM. C)
percentage of SCs expressing S100b (left) and Egr2/Krox20 (right) cultured in myelinating
medium, D) Raman spectra for nonmyelinating SCs.

Characterization of iPSC derived human Schwann cells
Once Schwann cells were differentiated using the 2 step differentiation protocol
developed by Kim et al, the identity of the Schwann cells was confirmed via phase microscopy
and immunocytochemistry [58]. By Day 7 iPSC-SCs form a confluent monolayer with some cells
beginning to show the characteristic spindle like morphology of Schwann cells, similar to that
seen in primary human SC monocultures (Fig 3A,B). ICC staining was done using two markers of
mature Schwann cell identity, myelin basic protein (MBP), and myelin proteolipid protein (PLP)
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which showed consistent co-localization of both marker with nucleus stain DAPI (Fig 3C,D,&E)
[58].

Figure 3: Characterization of iPSC derived SCs in monoculture A) phase contrast microscopy of
SCs at day 7 at10x magnification B) phase contract microscopy of SCs at 20x magnificationC)
immunocytochemistry of Schwann cell monoculture using marker MBP D) ICC of Schwann cell
monoculture using mature Schwann cell marker PLP E) Merged ICC image of markers MBP, PLP,
and DAPI showing co-localization of mature Schwann cell markers MBP and PLP along with
nuclear stain DAPI. Scale bars = 50µM.
Development and Characterization of iPSC Motoneuron- Primary Schwann Cell Co-Culture
To establish a protocol that produced significant myelination in the human co-cultures,
different combinations of cell plating sequences and timing, as well as timing of ascorbate
addition to the medium were evaluated. The optimal timeline for cell plating and ascorbate
addition for this model is described in Figure 4. By day 2 in co-culture, SCs formed a confluent
monolayer as they migrated underneath the axons of the day 7 iPSC-MNs (Fig. 5A). Day 15 iPSC-
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MNs exhibited development of axon fascicles while SCs were observed interacting with these
fascicles, which suggested the occurrence of radial sorting [16] (Fig. 5B). Day 31 axon regions
exhibited phase bright regions indicative of potential myelin formation (Fig. 5C).

Figure 4: Timeline for motoneuron + SC co-culture maturation and myelination.

Figure 5: Time course characterization of motoneuron + SC co-cultures A) day 2: monolayer
formation of SCs (left) and SC migration under MN axons (right), B) day 15: development of
axon fascicles (left) and SC interaction with MN axons (right, arrowhead), C) day 31: phase
bright axon regions suggestive of SC myelination. Scale bars = 50µm.
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Myelination characterization, quantification, and node of Ranvier formation
To determine if the phase bright regions visible throughout the co-cultures were myelin
segments, immunocytochemistry was performed on the day 31 co-cultures. S100b-positive SCs
were observed aligned to NF-H-positive iPSC-MN axons; MBP-positive segments were also
observed throughout the co-culture (Fig. 6). The efficiency of myelination was determined by
quantifying the number of myelin segments relative to the number of aligned S100b-positive
SCs across three cultures (Fig. 6A-C) and the overall myelination efficiency was 64.49±5.26%
(Table 1).
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Figure 6: Characterization of myelin segment formation at day 31 A) S100b channel indicating
SC alignment with MN axons (white arrowheads) B) MBP and NF co-localization indicating SC
myelination of MN axons (white arrowheads), C) merged image indicating high efficiency myelin
segment formation (white arrowheads). Scale bars = 50µm.

Table 1: Myelin segment quantification

Myelinated

Culture 1

Culture 2

Culture 3

Average of all three cultures

63.17±3.92

66.88±6.36

65.19±6.56

64.49±5.26

Segments

Percent myelin efficiency = (𝑛𝑜. 𝑚𝑦𝑒𝑙𝑖𝑛 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠)/(𝑛𝑜. 𝑎𝑙𝑖𝑔𝑛𝑒𝑑 𝑆𝐶𝑠)x100.
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As node of Ranvier formation is the developmental outcome of myelination,
immunocytochemistry was conducted on myelinating cultures to investigate the ability of the
system to facilitate node formation. At day 31, clusters of VGSCs (visualized with Nav-PAN) and
the paranodal cell adhesion molecule CASPR were observed indicating node of Ranvier
formation (Fig. 7). Specifically, clusters of VGSCs (Nav-PAN) were observed adjacent to regions
of paranodal CASPR (Fig. 7D). The magnified inset in Figure 7D shows the presence of clustered
VGSCs adjacent to paranodal Caspr indicative of node of Ranvier formation. Finally, by using
Raman spectroscopy, bands for myelinated axons were detected at 1445cm-1 (CH2 bending of
proteins and lipids), 1660cm-1 (C=C stretch of Amide I proteins), 2871cm-1 (CH2 symmetric
stretch of lipids and proteins), and 2960cm-1 (asymmetric CH3 stretch of lipids) [51, 60] (Fig. 8B).
These regions have been shown to be indicative of myelinated motoneurons in human ex vivo
spinal cord sections [53]. Using the peaks at 1650cm-1 and 2960cm-1, 3D renderings were
created to visualize the axon internal to the myelin sheath (Fig. 8C,D&E). Since 1650cm-1 is
indicative of proteins, it was selected to visualize the axon (Fig. 8D); whereas 2960cm-1,
indicative of lipids that are expected to be the predominant constituent of myelin, was used to
form the image representing the myelin sheath (Fig. 8E). Using the band at 1665cm-1, a
reconstruction of the myelin sheath was created, with the lower intensity signals subtracted to
highlight the axon track surrounded by myelin (Fig. 8F).
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Figure 7: Characterization of node of Ranvier formation A) cluster of VGSCs Nav-PAN, B)
paranodal protein CASPR, C) myelin basic protein D) merge image of Pan and Caspr staining
with magnified inset showing clustering of VGSCs adjacent to paranodal protein Caspr , Scale
bar = 100µm.

Figure 8: Confirmation of myelination using confocal Raman microscopy A) optical image of
the axon selected for Raman spectroscopic analysis, B) the Raman spectra acquired in the
selected region (red box in A) was determined; the blue line corresponds to the Raman spectrum
of the axon, and the red line to an unmyelinated axon, C) confocal Raman microscopy
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reconstruction with no signal subtraction of the myelinated axon obtained using the Raman
-1

band indicating the presence of an axon at 1650cm , D) confocal Raman microscopy
reconstruction with no signal subtraction of the myelinated axon using the Raman band
-1

indicating the presence of myelin at 2960cm , E) 3D overlay of C) and D) indicating myelination
(red/orange) flanking the MN axon (blue/green). F) confocal 3D Raman microscopy
-1

reconstruction of the myelinated axon obtained using the Raman band at 1665cm with lower
intensity signals removed to highlight the myelin sheath surrounding the axonal track.
Development and Characterization of iPSC Motoneuron-iPSC Schwann Cell Co-Culture
To optimize the previous protocol that was established utilizing primary human
Schwann cells for use with iPSC human Schwann cells, different plating times were evaluated to
determine which days of adding iPSC Schwann cells produced significant myelination in the iPSC
MN-iPSC SC co-cultures. Since the primary Schwann cells were assumed to have a further
degree of maturity compared to the freshly differentiated iPSC SCs, the plating of iPSC SCs at
the same time as iPSC MNs was seen to be most effective. The optimal timeline for cell plating
and ascorbate addition for this iPSC model is described in Figure 9. In addition to adjusting the
plating day for iPSC SCs, NRG1-III was also added to the medium to promote increased
myelination. At day 2 in co-culture, iPSC SCs and iPSC MNs are seen attached to the surface
(Fig. 10A). At Day 15 proliferation of SCs and the beginning of the formation of a SC monolayer
under the axons is seen, as well as phase bright areas along axons indicating the initiation of
interaction of SCs with axons one of the initial stages of myelination (Fig 10B). At Day 25 in coculture, iPSC-MNs exhibited development of long axons, and axon fascicles, as well as the
increasing formation of a SC monolayer underneath axons. Phase bright areas along the axons
show an increase of the number of iPSC SCs interacting with single axons which suggest the
progression of myelination initiation by Schwann cells interacting and elongating along the
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length of axons, and interaction with axon fascicles was also observed suggesting the
occurrence of radial sorting [16] (Fig. 10C). By Day 35, long axons were observed, as well as an
extensive monolayer formed by the iPSC SCs. Phase bright regions exhibited along the length of
axons suggest the presence of elongated Schwann cells along the axons, indicative of potential
myelin formation (Fig. 10D).

Figure 9: Timeline for motoneuron + SC co-culture maturation and myelination.
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Figure 10: Time course characterization of iPSC motoneuron + iPSC SC co-cultures A) Day 2:
adherence of iPSC MNs and iPSC SCs to surface), B) Day 15: SCs seen starting to proliferate to
form a monolayer underneath axons, as well as phase bright regions along axons indicating SCs
starting to interact with axons C) Day 25: development of axon fascicles and single axons, and
increased SC interaction with MN axons and fascicles (white arrows), D) day 35: phase bright
axon regions suggestive of SC myelination. Scale bars = 50µm.
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Myelination characterization
To determine if the phase bright regions visible along axons throughout the co-cultures
at Day 15 were aligned Schwann cells, immunocytochemistry was performed at days 15. At Day
15, small numbers of S100b and MBP-positive SCs were observed aligned to NF-positive iPSCMN axons confirming that the phase bright regions seen in phase were in fact SCs; the positive
staining for MBP suggests that the SCs are expressing myelination positive phenotype indicating
that myelination was initiated (Fig. 11). A Z-stack was done at Day 35, and a large number of
S100b and MBP positive SCs are seen in close proximity to each other, and are tightly
associated along the axon, suggesting the formation of compact myelin segments (Fig 12).
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Figure 11: Characterization of Schwann cell interaction along axons at day 15 A)
Neurofilament staining showing presence of axon B) S100b staining showing presence of
elongated Schwann cells, C) MBP staining showing presence of pro-myelinating Schwann cells,
D) DAPI stain showing SC nuclei, E) merged image of NF, S100b, MBP, and DAPI, showing
presence of pro-myelinating SCs aligned along axon. Scale bars = 50µm.

Figure 12: Characterization of Schwann cell myelination of axon at day 35 A)
Neurofilament+DAPI Z-stack showing presence of ~12 cell nuclei aligned along axon B)
S100b+DAPI Z-stack confirming that the aligned cells along the axon are elongated Schwann
cells, C) S100b+MBP+NF Z-stack showing compact myelin formation along the axon yellow
signal showing co-localization of S100b and MBP, D) Merged Z-stack image of
S100b+MBP+NF+DAPI signals. Scale bars = 50µm.
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CHAPTER 4: DISCUSSION
The work done here describes the development of a human-based in vitro myelination
model including node of Ranvier formation using human iPSC-derived MNs and human primary
SCs. Additional work using iPSC Schwann cells in place of primary human Schwann cells
indicating successful myelination via ICC is also described.
During the primary human SC characterization process, 41.6% of cells were found to express
Egr2 in the myelination promoting serum-free medium (Fig. 2C). This data supports the finding
that not all immature SCs develop the myelinating phenotype [61]. The percent of Egr2 positive
SCs could be a result of the adult source of the cells. However, since SCs retain the ability to
develop a myelinating phenotype during regeneration, data also suggests the medium could be
further optimized to increase Egr2 expression, thereby increasing the myelination efficiency in
vitro [1]. Schwann cell identity of iPSC derived Schwann cells was also confirmed via
immunocytochemistry using mature Schwann cell markers S100b and PLP [58]. While flow
cytometry is still yet to be done with the iPSC Schwann cells, we hypothesize that the
percentage of Egr2 positive cells of the iPSC SCs would be higher due to them being freshly
differentiated rather than those sourced from an adult human.
Radial sorting is the process by which SCs envelop an axon fascicle and select which
individual axons to myelinate [16]. During the in vivo maturation process, the SCs separate
axons from the axon fascicles and form a 1:1 axon to SC relationship; a phenomenon observed
in the later stages of both co-culture models presented (Fig. 6,11,&12). Phase images (Fig. 5B)
indicated what appeared to be SC alignment with axon bundles during what is presumed to be
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the pre-myelinating phase in the iPSC MN-primary SC co-culture. This SC alignment with axon
bundles as well as single axons was also observed in phase images of the iPSC MN-iPSC SC cocultures (Fig. 10C) displaying the similarities between stages of myelination between the
primary SC utilizing co-cultures and iPSC SC utilizing co-cultures. These results support findings
by Zollinger et al. and Nodari et al. indicating radial sorting of sensory neuron axons using DRG
explants [62, 63]. Immunocytochemistry with the SC marker S100b showed a similar phenotype
(Fig. 6A, 11,&12). Thus, our data suggests that radial sorting, a well-known in vivo mechanism of
myelination, is likely occurring in this model.
MBP colocalization with neurofilament was used to indicate myelin sheath formation in
iPSC MN-primary SC co-cultures (Fig. 6B) as well as in the iPSC MN-iPSC SC co-cultures (Fig. 12).
MBP staining along with S100b-positive SCs, made it possible to quantify myelination efficiency
(Table 1) in the iPSC MN-primary SC co-cultures. MBP positive staining was not observed
without the presence of S100b-positive SCs aligned with the same axon. However, SC alignment
did not always coincide with MBP segments confirming the established observations that a
subset of axons are myelinated based on specific criteria including axon diameter [16, 64, 65].
Node of Ranvier formation is an important feature of myelinated axons, where the
nodes consist of clusters of VGSCs in small unmyelinated regions between adjacent myelin
segments. The function of the nodes of Ranvier is to increase axonal conduction velocity
facilitating rapid transmission of information throughout the body [21]. On either side of VGSC
clusters are the proteins CASPR, contactin, and neurofascin 155, which establish paranodal axoglial junctions between the myelin sheath and the axon, as well as assist in the tight clustering
of the VGSCs [66]. Diseases that affect peripheral myelination often see increased reaction time
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from stimulation of the motoneuron to response of the muscle due to the loss of nodes of
Ranvier, making them an integral feature of any system that will be used to investigate
myelinating neuropathies [36]. By staining for Nav-PAN, we observed tight clustering of VGSCs,
between CASPR positive areas of the paranode indicating node of Ranvier formation in our iPSC
MN-primary Schwann cell co-culture system (Fig. 7). These results are similar to our previous
findings that indicated node of Ranvier formation in in vitro animal models [36, 67].
The standard for myelin segment analysis is TEM. In lieu of TEM, which is prohibitive for
analyzing myelination on coverslips, confocal Raman microscopy/spectroscopy was employed.
By combining confocal microscopy with Raman spectroscopy the analysis of the biochemical
nature of a sample locally is possible [49]. 3D confocal Raman microscopy presents a method of
characterization that requires little to no sample preparation. While we performed this analysis
using samples fixed with PFA, with the proper equipment (a stage heater) it is possible to do
the same imaging using live cultures, as well as allowing the potential to do quantifiable
analysis of myelin formation. Numerous studies analyzing in vivo myelinated and unmyelinated
axons and their Raman signatures have been reported [50, 52, 53, 59]. The Raman spectra
acquired from these in vitro co-cultures, the first of its kind, displayed the same characteristic
bands seen in in vivo studies. Here, the observations validate the immunocytochemistry results
and confirm that the in vitro myelination findings matched the in vivo data. When comparing
the spectra of unmyelinated and myelinated axons, significant changes in the 1650cm-1 and
2876cm-1 bands were observed (Fig.1,2, and 8). Considering that myelin is made up of 70%
lipids and 30% proteins while axons are made up of mostly filamentous proteins, the presence
of high intensity peaks of these lipid groups is expected in the presence of myelin [27, 68].
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Therefore, using the protein-related band (1650cm-1) and lipid-related band (2960cm-1), a 3D
rendering of a myelinated axon was constructed. By using 1650cm-1, a Raman intensity map
revealing the location of the axon was generated, while 2960cm-1 was used to identify myelin
(Fig. 8C&D respectively). By overlaying the two 3D stacked images, one can observe a
concentrated signal where the axon would be expected, while the concentrated signal of
2960cm-1 was observed to be much wider and surrounded the 1650cm-1 region, suggesting
successful myelination of the axon (Fig. 8E). Overlaying the two models shows the high intensity
axon peak at 1650cm -1 running down the center of the high intensity myelin peak at 2960cm -1
indicating the presence of a myelinated axon. (Fig. 8D). Subtraction of the low intensity signals
clearly indicates a 3D rendering of an axonal track surrounded by the myelin sheath (Fig. 8F).
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CHAPTER 5: CONCLUSION
The iPSC MN-primary SC myelination model developed here exhibited the hallmark
features of peripheral myelination including, SC alignment with axons, myelin segment
formation, and clustering of VGSCs and CAPSR. Immunocytochemistry facilitated visualization
of the characteristic features, and 3D confocal Raman microscopy/spectroscopy confirmed the
presence of myelinated axons by identifying myelin’s biochemical signature in the co-culture. In
vitro models of myelination, including the first organ-on-a-chip model, have been abundantly
described in the literature [36, 37, 41-44, 69]. However, they have largely been composed of
primary animal cells or of chimeras using rodent and human cells, especially neonatal SCs which
are known to actively myelinate moto- and sensory neuron axons ex vivo. While animal models
and in vitro models composed of animal cells have proven invaluable to investigating the
molecular mechanisms of peripheral nervous system myelination, the myelination model
described here, composed of human SCs and human iPSC-MNs, will be useful for investigating
the differences between animal and human myelination and for modeling demyelinating
peripheral neuropathies. Taking it a step further, the use of iPSC Schwann cells in place of
primary Schwann cells increases the applicability of using such an in vitro model when it comes
to modeling myelination in genetic diseases. iPSCs allow the differentiation of disease state
cells, and differentiating disease state SCs could allow accurate modelling of diseased
myelination allowing accurate elucidation of mechanisms that are affected, as well as testing of
potential therapeutics to recover functionality lost due to the disease.
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